Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Medley ( (JP:4480) ) has issued an announcement.
Medley, Inc. has announced corrections to its presentation materials for fiscal 2026 first-quarter financial results, specifically revising the breakdown of selling, general and administrative expenses. The adjustment affects only the internal classification of SG&A, leaving total SG&A and other headline figures for the quarter unchanged.
The company stated that the corrected financial presentation is now available on its investor relations website, ensuring stakeholders have access to accurate expense details. The clarification aims to maintain transparency in Medley’s financial disclosures and avoid any misinterpretation of its cost structure or operating performance.
The most recent analyst rating on (JP:4480) stock is a Buy with a Yen4500.00 price target. To see the full list of analyst forecasts on Medley stock, see the JP:4480 Stock Forecast page.
More about Medley
Medley, Inc. is a Japan-based company listed on the Tokyo Stock Exchange Prime Market that provides services in the medical and healthcare-related field. The company focuses on digital solutions and platforms for the healthcare industry, targeting stakeholders across medical services and related sectors.
Average Trading Volume: 448,987
Technical Sentiment Signal: Sell
Current Market Cap: Yen70.91B
See more insights into 4480 stock on TipRanks’ Stock Analysis page.